REMINDER: The reminder to those pharmacies who wish to send in a return with the number of patients currently being provided with adherence support has been extended beyond 3rd May 2024.
Dear Contractor
Correspondence has been issued by SPPG 4th April 2024 regarding Community Pharmacy Adherence Support.
SUMMARY
Since 1st May 2023 the Drug Tariff has been changed so that instalment dispensing is an exception facility for use only where the prescriber considers it essential to prevent abuse or misuse.
As public funding is being utilised to support community pharmacies in meeting their obligations under the Disability Discrimination Act 1995 (DDA), SPPG are requesting information on the number of patients currently being provided with adherence support.
Adherence support includes provision of a Monitored Dosage System (MDS), pill crushers, reminder charts/alarms, or dexterity aids.
All patients receiving adherence support should be included with the following exceptions:
Patients who reside in Care Homes whose medicines are provided via MDS.
Patients with an instalment endorsement to prevent misuse or abuse of their medicines i.e. dispensing in skillets for daily or weekly patients. Please note: where these patients receive a form of adherence support such as MDS, they should be included on your list. There are instances where a patient receives both instalment dispensing and adherence support.
Patients who do not require support as a reasonable adjustment under DDA but for whom the pharmacy still provide adherence support e.g. requested for convenience.
The quarterly adherence return which was previously required will now be stood down.
ACTION
Contractors are asked to review the reminder issued by SPPG 26th April 2024 regarding Community Pharmacy Adherence Support and share with relevant team members.
SPPG are requesting those pharmacies who have yet to send a return to do so by using the following link by Friday 3rd May 2024.
The quarterly adherence return will now be stood down and is no longer required.
Guidance is available which provides information to community pharmacies in relation to their statutory requirements under DDA.
For any further information please contact CPNI offices.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
SPPG have issued correspondence on 14th May regarding the Living Well Service.
SUMMARY
The measles, mumps and rubella (MMR) vaccination campaign is to begin on 1st June 2024.
Various resources will be provided and if these are not received by 31st May 2024, SPPG have asked community pharmacies to email reception.pha@hscni.net immediately and title the subject heading as ‘LIVING WELL PHARMACY CAMPAIGN’.
Replacement resources cannot be provided if not reported by 7th June 2024.
Resources posted by PHA can be shared on social media channels to increase the reach of the campaign. Details of this schedule along with printable resources can be found here.
A presentation on MMR has been created by PHA and can be accessed here.
The campaign for ‘cancer screening saves lives’ will finish on 31st May 2024, and the survey will open between 3rd June 2024 and 6pm 3rd July 2024.
When completing a survey please ensure to use the correct contractor number. It is advised to take a picture of the confirmation text at the end of the process and/or tick the box to save a copy of your answers.
Resources can be displayed to the public, and pharmacies are asked not to compromise cleaning for infection control. To minimise infection risk, please promote the online resources and hand hygiene alongside booklet stock.
ACTION
Contractors are asked to read the correspondence issued by SPPG on 14th May 2024 regarding the Living Well Service and share with all relevant members of the team.
The next campaign ‘MMR vaccination’ begins on 1st June 2024 and if resources are not received by 31st May 2024 email reception.pha@hscni.net immediately. Please ensure the email subject is titled ‘LIVING WELL PHARMACY CAMPAIGN’. Failure to report this by 7th June 2024 will result in no resources being provided.
The current campaign ‘cancer screening saves lives’ will finish on 31st May 2024 and the survey will run from 3rd June 2024 to 6pm 3rd July.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor,
A brief update on 2025/26 Foundation Training Year arrangements from Mr. Peter Rice, Chairman of CPNI, is provided here.
Yours sincerely,
SENT ON BEHALF OF GERARD GREENE Chief Executive
This update contains important information for community pharmacy teams.
Community Pharmacy Awareness Campaign – Extended to 17th May 2024
Thank you for supporting the community pharmacy campaign which calls for fair funding for pharmacies. We hope the resources have been helpful when engaging with patients and the wider community.
With the availability of additional video resources, we have extended the campaign timeframe until the week ending the 17th of May 2024. This will give contractors the opportunity to share the social media assets across their social media channels. You may consider adding your own experiences. If you need additional petition copies they are available here.
I would encourage you to make your pharmacists and the wider pharmacy team aware of the campaign and the important impact patients and customers can make in supporting it.
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor,
Thank you for supporting the community pharmacy campaign which calls for fair funding for pharmacies. We hope the resources have been helpful when engaging with patients and the wider community.
With the availability of additional video resources, we have extended the campaign timeframe until the week ending the 17th of May 2024. This will give contractors the opportunity to share the social media assets across their social media channels. You may consider adding your own experiences. If you need additional petition copies they are available here.
I would encourage you to make your pharmacists and the wider pharmacy team aware of the campaign and the important impact patients and customers can make in supporting it.
Thank you again for your support.
Yours sincerely,
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
SPPG have issued an important reminder to check the expiry date of Spikevax® XBB.1.5 stock.
SUMMARY
Some vaccines that were provided early in the Spring Booster Campaign have an expiry date of the 11th May 2024.
Due to Spikevax® XBB.1.5 vaccine having a thawed expiry date of 30 days, any stock that was delivered in the first week of April will also be expired. The thawed expiry date should be noted on the outside of the box by Movianto.
Quotas at Movianto have now been reset to allow further orders to facilitate stock replenishment.
Due to the 30 day expiry, orders should only be placed within 2 weeks of clinics taking place.
ACTION
Contractors are asked to review the correspondence issued by SPPG on 9th May 2024 regarding the Spring COVID-19 vaccine.
Pharmacies are asked to check all expiry dates of Spikevax® XBB.1.5 vaccine stock and dispose of any that are out of date.
Please share this information with all relevant staff members
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.